SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

Medicenna Says MDNA209 Extends Survival Up to Fourfold in Mouse Models

The company reported that MDNA209 extended median survival up to fourfold in mouse models of acute graft-versus-host disease.

Related stories